A Transcriptional Roadmap to the Induction of Pluripotency in Somatic Cells

Ying Wang,Nancy Mah,Alessandro Prigione,Katharina Wolfrum,Miguel A. Andrade-Navarro,James Adjaye

DOI: https://doi.org/10.1007/s12015-010-9137-2

2010-03-25

Stem Cell Reviews and Reports

Abstract:Human embryonic stem (ES) cells possess an enormous potential for applications in regenerative medicine. However, these cells have several inevitable hurdles limiting their clinical applications, such as transplant rejection and embryo destruction. A milestone recently achieved was the derivation of induced pluripotent stem (iPS) cells by over-expressing combinations of defined transcription factors, namely, OCT4, SOX2, NANOG, and LIN28 or OCT4, SOX2, KLF4, and c-MYC. Human iPS cells exhibit many characteristics identical to those of inner cell mass-derived ES cells. Here, we summarize the generation of human fibroblast-derived iPS cells and discuss the promises and limitations of their use. In addition, by utilising numerous published transcriptome datasets related to ES cells, fibroblast-derived iPS cells, partially induced pluripotent stem cells (PiPSC) and wild type fibroblasts, we reveal similarities (self-renewal signature) and differences (donor cell-type and PiPSC signatures) in genes and associated signaling pathways operative in the induction of pluripotency in fibroblasts. In particular, we highlight that induction of ground state pluripotency is also favoured by the inhibition of epithelial mesenchymal transition (EMT) and hence the induction of mesenchymal epithelial transition (MET). We anticipate that these findings might aid in the establishment of more efficient protocols for inducing pluripotency in somatic cells.

cell biology,medicine, research & experimental,cell & tissue engineering

What problem does this paper attempt to address?

The problem that this paper attempts to solve is about how to induce the reprogramming of somatic cells (such as fibroblasts) into induced pluripotent stem cells (iPS cells) through the over - expression of specific transcription factors, as well as the application potential and limitations of these iPS cells in regenerative medicine. Specifically:

1. **Generation of Induced Pluripotent Stem Cells**: The paper explores the methods of reprogramming human fibroblasts into iPS cells by over - expressing specific transcription factors (such as OCT4, SOX2, KLF4 and c - MYC or OCT4, SOX2, NANOG and LIN28). These iPS cells exhibit properties similar to embryonic stem cells (ES cells), such as self - renewal ability and pluripotency.

2. **Research on Reprogramming Mechanisms**: The authors used the published transcriptome data sets to compare the gene expression patterns among ES cells, iPS cells derived from fibroblasts, partially induced pluripotent stem cells (PiPSC) and wild - type fibroblasts. They discovered the similarities and differences in genes and signaling pathways that play a role in the process of inducing pluripotency, especially emphasizing the favorable effects of inhibiting epithelial - mesenchymal transition (EMT) and promoting mesenchymal - epithelial transition (MET) on inducing "ground - state" pluripotency.

3. **Applications and Challenges of iPS Cells**: The paper discusses the application potential of iPS cells in basic research, drug screening and clinical treatment, and also points out some obstacles that need to be overcome before applying iPS cells in the clinic, such as low reprogramming efficiency, gene mutation risk and genomic instability, etc.

In summary, this paper aims to comprehensively summarize and analyze the generation methods of iPS cells and their application prospects in the field of regenerative medicine, and also explores some strategies for improving reprogramming efficiency and safety.